LONDON (AP) — AstraZeneca said Thursday that it intends to seek U.S. approval for its COVID-19 vaccine in the second half of this year, further delaying the long-awaited application. The Anglo-Swedish drugmaker announced the new timetable as it said the company and its partners have delivered more than 1 billion doses of the vaccine to…… MORE